ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,048.42
      -0.46%
      US Tech 100
      17,162.80
      0.60%
      Dow Jones
      38,085.80
      -0.98%
      Brent Oil
      88.195
      0.05%
      Bitcoin
      64,186.39
      -0.46%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. NeuBase Therapeutics Inc (NBSE)

      7. NeuBase Therapeutics Inc (NBSE) News

      NBSE NeuBase Therapeutics Inc

      0.442
      0.0087 (2.01%)
      Apr 25 2024 - Closed
      Delayed by 15 minutes
      Company Name Stock Ticker Symbol Market Type
      NeuBase Therapeutics Inc NBSE NASDAQ Common Stock
        Price Change Change Percent Stock Price Last Traded
      Upgrade Icon
      0.0087 2.01% 0.442 17:10:00
      Open Price Low Price High Price Close Price Prev Close
      0.428 0.428 0.449 0.442 0.4333
      more quote information »

      Recent News

      Date Time Source Heading
      4/25/20248:52IHNWFeaturedCannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA
      4/05/202416:05GLOBENeuBase Therapeutics Announces Receipt of Notice from Nasdaq
      3/07/202416:01EDGAR2Form 8-K - Current report
      2/23/202416:01EDGAR2Form 8-K - Current report
      1/26/202408:00EDGAR2Form 8-K - Current report
      1/17/202406:15EDGAR2Form 8-K - Current report
      12/28/202307:00EDGAR2Form 8-K - Current report
      12/28/202306:15EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
      12/22/202306:15EDGAR2Form 8-K - Current report
      11/27/202309:00GLOBEPsychemedics Corporation Appoints Daniella Mehalik as VP -..
      11/09/202316:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      11/06/202317:00EDGAR2Form 8-K - Current report
      10/20/202307:30EDGAR2Form 8-K - Current report
      10/18/202308:00EDGAR2Form 8-K - Current report
      9/29/202316:10EDGAR2Form 8-K - Current report
      9/20/202320:42EDGAR2Form 5 - Annual statement of changes in beneficial ownership..
      9/20/202317:28EDGAR2Form SC 13D/A - General statement of acquisition of..
      9/18/202316:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      9/18/202316:20EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
      9/18/202316:17EDGAR2Form 8-K - Current report
      9/14/202306:03EDGAR2Form SC 13D/A - General statement of acquisition of..
      9/11/202317:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      9/08/202307:00GLOBENeuBase Therapeutics Issues Statement Regarding Filing By..
      9/07/202317:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      9/06/202310:00PRNUSSYMETRYX CORPORATION ACQUIRES 20% STOCK IN NEUBASE
      8/31/202311:50EDGAR2Form SC 13D - General statement of acquisition of beneficial..
      8/14/202316:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      8/11/202306:18EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
      8/11/202306:15EDGAR2Form DEF 14A - Other definitive proxy statements
      8/10/202317:13EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
      8/04/202316:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      8/03/202307:05EDGAR2Form 8-K - Current report
      8/01/202316:45EDGAR2Form PRE 14A - Other preliminary proxy statements
      7/31/202316:10EDGAR2Form 8-K - Current report
      7/28/202306:03EDGAR2Form S-1 - General form for registration of securities under..
      6/30/202316:21EDGAR2Form 8-K - Current report
      6/30/202308:42EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
      6/30/202308:41EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]

      Your Recent History

      NASDAQ
      NBSE
      NeuBase Therapeutics
      Delayed Upgrade Clock